Clinical Trial Update: Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Open-label Phase 1 clinical trial evaluating BBO-10203 in adults with advanced, metastatic solid tumors; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Lung Cancer
• Solid Tumors

Drugs mentioned

• BBO-10203

Snippet

Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) | Conditions: Solid Tumor, Adult, Metastatic Breast Cancer | Phase 1 | Status: RECRUITING